Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease.

被引：0
|
作者：
Angelico, Mario
Baiocchi, Leonardo
Perrone, Luciano
Petrolati, Alessandra
Lenci, Ilaria
Tariciotti, Laura
Sforza, Daniele
Iaria, Giuseppe
Palmieri, Giampiero
Tisone, Giuseppe
机构：
[1] Univ Roma Tor Vergata, Liver Transplant Ctr, I-00173 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Pathol, I-00173 Rome, Italy
来源：
LIVER TRANSPLANTATION | 2007年 / 13卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
556
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [31] Engraftment and survival of transplanted hepatocytes in the cirrhotic liver indicates the potential of liver repopulation in chronic liver disease.
    Rajvanshi, P
    Bhargava, KK
    Palestro, CJ
    Gupta, S
    HEPATOLOGY, 1996, 24 (04) : 730 - 730
  • [32] LIVER-DISEASE IN TRANSPLANTED PATIENTS
    PIRSON, Y
    VANYPERS.C
    KIDNEY INTERNATIONAL, 1973, 3 (05) : A7 - A8
  • [33] FOLLOW-UP OF LIVER FIBROSIS IN HCV PATIENTS. A COMPARISON BETWEEN LIVER BIOPSY AND LIVER STIFFNESS MEASUREMENT
    Vergniol, Julien
    Foucher, Juliette
    Le Bail, Brigitte
    Chermak, Faiza
    Liccioni, Alexandre
    Messaoudi, Nawel
    Merrouche, Wassil
    de Ledinghen, Victor
    HEPATOLOGY, 2011, 54 : 567A - 567A
  • [34] The Role of Transforming Growth Factor β-1 Polymorphism in the Fibrosis Progression after Liver Transplantation for HCV-Induced Liver Disease.
    Eurich, Dennis
    Boas-Knoop, Sabine
    Lock, Johann F.
    Golembus, Jennifer
    Neuhaus, Ruth
    Neuhaus, Peter
    Neumann, Ulf P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 134 - 134
  • [35] HCV Genotypes and Cellular Immune Response in Correlation to Liver Fibrosis
    Gabr, Sami A.
    Alghadir, Ahmad H.
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2013, 7 : 117 - 129
  • [36] Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
    Ballestri, Stefano
    Mantovani, Alessandro
    Di Girolamo, Maria
    Baldelli, Enrica
    Capitelli, Mariano
    Lonardo, Amedeo
    METABOLISM AND TARGET ORGAN DAMAGE, 2023, 3 (01):
  • [37] Occult HCV infection in liver transplanted patients: frequency and consequences
    Saad, Zeinab M.
    Ghany, Wael Abd El
    Khalifa, Rofida
    Higazi, Aliaa
    Al-Shazly, Mostafa
    Said, Mohamed
    Keryakos, Hesham
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 8 (02) : 125 - 131
  • [38] Liver disease and HCV replication in patients with chronic hepatitis C and/or homozygous sickle cell disease.
    Bastie, A
    Blanc, L
    Lee, K
    Bachir, D
    RoudotThoraval, F
    Remire, J
    Darthuy, F
    Galacteros, F
    Duval, J
    Dhumeaux, D
    Pawlotsky, JM
    HEPATOLOGY, 1996, 24 (04) : 1419 - 1419
  • [39] Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis
    Siegmund, Soeren V.
    Schwabe, Robert F.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 294 (02): : G357 - G362
  • [40] Nonalcoholic Fatty Liver Disease: Identifying Patients at Risk of Inflammation or Fibrosis
    Osayande, Amimi S.
    Kale, Neelima
    AMERICAN FAMILY PHYSICIAN, 2017, 95 (12) : 796 - 797
12345